26.25 USD
-0.35 (-1.32%)
26.25 USD
0 (0%)
AMPH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 190 industry peers in the Pharmaceuticals industry. While AMPH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AMPH may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, AMPH could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
- In the past year AMPH was profitable.
- AMPH had a positive operating cash flow in the past year.
- Each year in the past 5 years AMPH has been profitable.
- Each year in the past 5 years AMPH had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 6.70%, AMPH belongs to the best of the industry, outperforming 87.89% of the companies in the same industry.
- AMPH has a Return On Equity of 14.37%. This is amongst the best in the industry. AMPH outperforms 88.42% of its industry peers.
- AMPH has a Return On Invested Capital of 8.51%. This is amongst the best in the industry. AMPH outperforms 86.84% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for AMPH is in line with the industry average of 12.83%.
- The last Return On Invested Capital (8.51%) for AMPH is well below the 3 year average (12.92%), which needs to be investigated, but indicates that AMPH had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.7% | ||
| ROE | 14.37% | ||
| ROIC | 8.51% |
ROA(3y)10.51%
ROA(5y)8.2%
ROE(3y)20.19%
ROE(5y)14.97%
ROIC(3y)12.92%
ROIC(5y)10.14%
1.3 Margins
- AMPH has a Profit Margin of 15.43%. This is amongst the best in the industry. AMPH outperforms 87.37% of its industry peers.
- AMPH's Profit Margin has improved in the last couple of years.
- AMPH has a better Operating Margin (20.73%) than 87.89% of its industry peers.
- AMPH's Operating Margin has improved in the last couple of years.
- With a decent Gross Margin value of 49.36%, AMPH is doing good in the industry, outperforming 64.21% of the companies in the same industry.
- AMPH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.73% | ||
| PM (TTM) | 15.43% | ||
| GM | 49.36% |
OM growth 3Y20.68%
OM growth 5YN/A
PM growth 3Y15.39%
PM growth 5Y7.52%
GM growth 3Y3.84%
GM growth 5Y4.54%
2. Health
2.1 Basic Checks
- AMPH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, AMPH has less shares outstanding
- AMPH has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AMPH has an improved debt to assets ratio.
2.2 Solvency
- AMPH has an Altman-Z score of 2.41. This is not the best score and indicates that AMPH is in the grey zone with still only limited risk for bankruptcy at the moment.
- AMPH's Altman-Z score of 2.41 is fine compared to the rest of the industry. AMPH outperforms 64.21% of its industry peers.
- AMPH has a debt to FCF ratio of 5.49. This is a neutral value as AMPH would need 5.49 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 5.49, AMPH belongs to the top of the industry, outperforming 82.11% of the companies in the same industry.
- A Debt/Equity ratio of 0.78 indicates that AMPH is somewhat dependend on debt financing.
- AMPH's Debt to Equity ratio of 0.78 is on the low side compared to the rest of the industry. AMPH is outperformed by 70.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 5.49 | ||
| Altman-Z | 2.41 |
ROIC/WACC0.95
WACC8.93%
2.3 Liquidity
- A Current Ratio of 3.12 indicates that AMPH has no problem at all paying its short term obligations.
- AMPH has a Current ratio of 3.12. This is comparable to the rest of the industry: AMPH outperforms 53.68% of its industry peers.
- AMPH has a Quick Ratio of 2.21. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
- AMPH has a Quick ratio of 2.21. This is comparable to the rest of the industry: AMPH outperforms 46.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.12 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
- AMPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.95%.
- AMPH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 61.62% yearly.
- Looking at the last year, AMPH shows a decrease in Revenue. The Revenue has decreased by -0.03% in the last year.
- AMPH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.82% yearly.
EPS 1Y (TTM)-9.95%
EPS 3Y41.58%
EPS 5Y61.62%
EPS Q2Q%-3.12%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y18.69%
Revenue growth 5Y17.82%
Sales Q2Q%0.33%
3.2 Future
- AMPH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.14% yearly.
- The Revenue is expected to grow by 4.14% on average over the next years.
EPS Next Y-8.73%
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
EPS Next 5Y0.14%
Revenue Next Year-0.8%
Revenue Next 2Y1.99%
Revenue Next 3Y2.7%
Revenue Next 5Y4.14%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- AMPH is valuated cheaply with a Price/Earnings ratio of 7.63.
- Compared to the rest of the industry, the Price/Earnings ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 93.16% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of AMPH to the average of the S&P500 Index (28.87), we can say AMPH is valued rather cheaply.
- AMPH is valuated cheaply with a Price/Forward Earnings ratio of 7.07.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 92.63% of the companies listed in the same industry.
- AMPH is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.63 | ||
| Fwd PE | 7.07 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 91.05% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 90.53% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.87 | ||
| EV/EBITDA | 7.38 |
4.3 Compensation for Growth
- The excellent profitability rating of AMPH may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
5. Dividend
5.1 Amount
- No dividends for AMPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMPHASTAR PHARMACEUTICALS IN / AMPH FAQ
What is the fundamental rating for AMPH stock?
ChartMill assigns a fundamental rating of 6 / 10 to AMPH.
What is the valuation status of AMPHASTAR PHARMACEUTICALS IN (AMPH) stock?
ChartMill assigns a valuation rating of 8 / 10 to AMPHASTAR PHARMACEUTICALS IN (AMPH). This can be considered as Undervalued.
Can you provide the profitability details for AMPHASTAR PHARMACEUTICALS IN?
AMPHASTAR PHARMACEUTICALS IN (AMPH) has a profitability rating of 9 / 10.
What is the valuation of AMPHASTAR PHARMACEUTICALS IN based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMPHASTAR PHARMACEUTICALS IN (AMPH) is 7.63 and the Price/Book (PB) ratio is 1.55.